Latest Breaking News On - Euronext growth adviser - Page 5 : comparemela.com

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan, has signed a £10.4m contract with an existing top 5 global .

France generalUnited kingdomCity ofTower hamletsAnthony farrell walbrookYamin khanYamin mo khanAndrew catchpoleRegulatory information serviceCompany disease in motionOpen orphanBig pharmaManufacturing practiceMo khanChief executive officerChief scientific officer